Noven Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
- Noven Pharmaceuticals has 1242 Employees.
- Noven Pharmaceuticals currently has 1 job openings.
What Is Noven Pharmaceuticals?
Noven Pharmaceuticals, Inc. (Nasdaq: NOVN), headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Our principal growth strategy is to apply our patented DOT Matrix® transdermal technology across diverse therapeutic categories with strong industry partners. Our patches are sold in over 30 countries, and a range of new prescription patches are under development. Together with Novartis Pharmaceuticals Corporation, we own Novogyne Pharmaceuticals, a successful women’s health products company with net sales of over $100 million in 2003. Novogyne’s lead product is Vivelle Dot® (estradiol transdermal system) – the smallest estrogen patch in the world and the most dispensed estrogen patch in the U.S. With the most advanced transdermal technology on the market, we are committed to expanding the universe of transdermal therapies for the benefit of patients, industry partners and shareholders.keywords:N/A